the proposed mechanisms also include immunomodulation through PD-1/PD-L1 blockade, which has shown a response in up to 13 to 17% of gynecological cancers, probably due to the immunosuppressive effect that occurs in the microenvironment in tumors. Here, CD274 is linked to female reproductive organ cancer.